ISA has relocated to brand new Biopartner 5 building

ISA Pharmaceuticals to present at the Virtual European Biotech Investor Day 2020

ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration with Regeneron

ISA in the news: MedNous’ article on CervISA

ISA Pharmaceuticals B.V. receives EUR 20m loan from European Investment Bank